Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-24-013071

CHIEF OPERATING OFFICER sold 260 shares at $25.06 ($6,515)

  • CHIEF OPERATING OFFICER acquired 260 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Patel Anish CHIEF OPERATING OFFICER 2024-05-09 Option exercise 10b5-1 +260 $2.48 $645 260 D: show line 1 in the form
Patel Anish CHIEF OPERATING OFFICER 2024-05-09 Sale 10b5-1 −260 $25.06 $6,515 0 D: show line 2 in the form
Open-market sales · 260 sh · avg $25.06 · $6,515

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Patel Anish CHIEF OPERATING OFFICER 2024-05-09 Option exercise · Employee Stock Option (right to buy) 10b5-1 −260 55,582 D: show line 3 in the form
Loading xslF345X05/form4-05132024_110543.xml…